B Cell Receptors in TCL1 Transgenic Mice Resemble Those of Aggressive, Treatment-Resistant Human Chronic Lymphocytic Leukemia

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0604564103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

TCL1 Transgenic Mice as a Model for CD49d-high Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia

Annals of Hematology
MedicineHematology
1990English

Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia

Journal of Experimental Medicine
MedicineAllergyImmunology
1997English

Targeting the B Cell Receptor Pathway in Chronic Lymphocytic Leukemia

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2012English

Deregulated Expression of TCL1 Causes T Cell Leukemia in Mice

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Metformin Inhibits Cell Cycle Progression of B-Cell Chronic Lymphocytic Leukemia Cells

Oncotarget
Oncology
2015English

Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).

International Journal of Advanced Research
2017English

Tcl1 Expression in Chronic Lymphocytic Leukemia Is Regulated by miR-29 and miR-181

Cancer Research
Cancer ResearchOncology
2006English

Induction of Apoptosis by 2-Chlorodeoxyadenosine in B Cell Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy